AMGN

7 Biotechnology Stocks to Buy Now

This week, seven biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

7 Biotechnology Stocks to Buy Now

This week, seven biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

Among Biotechs, Amgen Stock Offers Dividend Income

Biotech giant AMGN has a nice benefit Amgen stock in that it pays a dividend. With a low payout ratio, investors should look for increases in the future. More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

AMGN: Amgen Stock Future Looks Bright for Investors

Amgen released earnings that put a smile on investor's faces, and Amgen stock looks like a solid buy for the long term More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

Avoid the Usual Suspects, Buy These 2 True Defensive Stocks

Ignore most of the Wall Street bluster about defensive stocks. Instead, buy these two stocks which have solid fundamentals backing them up. More